financetom
Business
financetom
/
Business
/
RBC Reviews Manulife Financial's Q3
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
RBC Reviews Manulife Financial's Q3
Nov 9, 2024 12:19 PM

10:51 AM EST, 11/07/2024 (MT Newswires) -- Manulife Financial's ( MFC ) third-quarter core EPS of $1.00 was above RBC's estimate of $0.90 and consensus of $0.94. Core earnings and EPS benefited from $70 million of tax benefits in the quarter or about $0.04 per share, notes RBC analyst Darko Mihelic.

"MFC's core EPS was higher than we expected, but the strength in GWAM was in part due to tax benefits which we do not expect to repeat and Asia earnings were weaker than we expected, and hence while the core EPS was overall higher than we expected, we view this as a slightly positive quarter."

Manulife is rated Outperform, with a $39 target.

Price: 45.48, Change: +1.91, Percent Change: +4.38

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Snowflake Shares Rise After Company Beats Q4 Estimates, Expands Microsoft Partnership
Snowflake Shares Rise After Company Beats Q4 Estimates, Expands Microsoft Partnership
Feb 27, 2025
Snowflake Inc. ( SNOW ) shares are trading higher Thursday after the company reported better-than-expected fourth-quarter results and announced an expanded partnership with Microsoft Inc. . What To Know: The company posted earnings of 30 cents per share, beating analyst estimates of 17 cents. Revenue came in at $986.77 million, above the $955.93 million consensus and up from $774.7 million...
Madrigal Pharmaceuticals Shares Still Undervalued Amid Long-Term Growth Potential, UBS Says
Madrigal Pharmaceuticals Shares Still Undervalued Amid Long-Term Growth Potential, UBS Says
Feb 27, 2025
12:36 PM EST, 02/27/2025 (MT Newswires) -- Madrigal Pharmaceuticals' ( MDGL ) shares remain undervalued given the company's long-term potential opportunity from its Rezdiffra MASH business, UBS said Thursday in a note. The firm's upbeat outlook comes a day after the company said patients with metabolic dysfunction-associated steatohepatitis, or MASH, treated with its Rezdiffra drug showed marked reductions in liver...
US CFPB dismisses lawsuit against Berkshire unit over risky home loans
US CFPB dismisses lawsuit against Berkshire unit over risky home loans
Feb 27, 2025
Feb 27 (Reuters) - The U.S. Consumer Financial Protection Bureau dismissed its lawsuit accusing Vanderbilt Mortgage and Finance, a unit of Warren Buffett's Berkshire Hathaway ( BRK/A ), of driving borrowers into loans they could not afford to buy homes from Berkshire's Clayton Homes unit. Thursday's voluntary dismissal is part of a broad retrenchment in enforcement by the CFPB, which...
Update: AAON's Shares Fall Sharply After Q4 Adjusted Earnings, Revenue Fall
Update: AAON's Shares Fall Sharply After Q4 Adjusted Earnings, Revenue Fall
Feb 27, 2025
12:34 PM EST, 02/27/2025 (MT Newswires) -- (Updates with the latest stock movement in the first paragraph and headline.) AAON ( AAON ) shares were down over 17% in recent Thursday trading after the company reported lower Q4 results that missed analysts' expectations. The company reported Q4 adjusted earnings Thursday of $0.30 per diluted share, down from $0.56 a year...
Copyright 2023-2026 - www.financetom.com All Rights Reserved